Literature DB >> 8832720

Mutation analysis in Canadian families with choroideremia.

N Nesslinger1, G Mitchell, P Strasberg, I M MacDonald.   

Abstract

Choroideremia (CHM) is an X-linked heritable progressive dystrophy of the choroid and retina. The condition predominantly affects males beginning in early childhood and eventually results in blindness after a period of 30-40 years. The CHM gene was localized to Xq21 and cloned in the past few years. The gene encodes for Rab escort protein-I, a protein involved in the isoprenylation of intracellular proteins. With the isolation of the gene, a number of mutations have been identified in patients affected by CHM using molecular techniques. Our group reports the characterization of mutations in four Canadian families affected by CHM. In addition, an intragenic polymorphism was identified in exon 5. Finding the mutations in these families will result in accurate predictive testing for carriers, avoid unnecessary repeated examination of at-risk individuals, and add to our understanding of the cause of this disorder.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8832720     DOI: 10.3109/13816819609057870

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  7 in total

1.  Heterogeneous gene expression from the inactive X chromosome: an X-linked gene that escapes X inactivation in some human cell lines but is inactivated in others.

Authors:  L Carrel; H F Willard
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

2.  Novel types of mutation in the choroideremia ( CHM) gene: a full-length L1 insertion and an intronic mutation activating a cryptic exon.

Authors:  José A J M van den Hurk; Dorien J R van de Pol; Bernd Wissinger; Marc A van Driel; Lies H Hoefsloot; Ilse J de Wijs; L Ingeborgh van den Born; John R Heckenlively; Han G Brunner; Eberhart Zrenner; Hans-Hilger Ropers; Frans P M Cremers
Journal:  Hum Genet       Date:  2003-06-25       Impact factor: 4.132

3.  A novel mutation (967-970+2)delAAAGGT in the choroideremia gene found in a Japanese family and related clinical findings.

Authors:  Yutaka Iino; Takuro Fujimaki; Keiko Fujiki; Akira Murakami
Journal:  Jpn J Ophthalmol       Date:  2008-09-05       Impact factor: 2.447

4.  Molecular genetic diagnostic techniques in choroideremia.

Authors:  Mira J B Furgoch; Jacqueline Mewes-Arès; Alina Radziwon; Ian M Macdonald
Journal:  Mol Vis       Date:  2014-04-25       Impact factor: 2.367

5.  Analysis of a large choroideremia dataset does not suggest a preference for inclusion of certain genotypes in future trials of gene therapy.

Authors:  Paul R Freund; Yuri V Sergeev; Ian M MacDonald
Journal:  Mol Genet Genomic Med       Date:  2016-02-28       Impact factor: 2.183

Review 6.  Recent advances and future prospects in choroideremia.

Authors:  Martin S Zinkernagel; Robert E MacLaren
Journal:  Clin Ophthalmol       Date:  2015-11-23

7.  Next-generation sequencing-based clinical diagnosis of choroideremia and comprehensive mutational and clinical analyses.

Authors:  Feng-Juan Gao; Guo-Hong Tian; Fang-Yuan Hu; Dan-Dan Wang; Jian-Kang Li; Qing Chang; Fang Chen; Ge-Zhi Xu; Wei Liu; Ji-Hong Wu
Journal:  BMC Ophthalmol       Date:  2020-06-01       Impact factor: 2.209

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.